0.32 USD
▲+0.02+5.77%
盘后 0.31 0.00%
2026-09-16
市值
$9.70M
市盈率
—
EPS
-1.71
股息率
—
52 周区间
0.29 – 2.88
成交量
5.54M
Beta
2.12
目标价
13.50
52W 低 0.2952W 高 2.88
价格走势
公司简介
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company’s lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. It offers SENTI-202, a logic gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers and relapsed...